Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about New biological mechanism that causes cancer found
In a landmark study, researchers have found that unusual changes in the instructions for how the genome folds up on itself could be a completely new biological mechanism that underlies cancer.
- Read more about Hepatitis C infection may increase Parkinson's risk
Hepatitis C, a liver infection caused by a virus, may increase the risk of developing Parkinson's disease, a common degenerative brain disorder.
- Read more about Music therapy helps recovery from respiratory disorders
Music therapy can increase effectiveness of standard rehabilitation that patients with chronic obstructive pulmonary disease (COPD) and other chronic respiratory disorders receive, said a new study.
- Read more about Low vitamin D levels don't worsen sleep apnea
Contradicting common perception, researchers have found that low levels of vitamin D, also known as the "sunshine vitamin", does not cause or worsen sleep apnea.
- Read more about Campaign to combat anaemia among teenagers launched
Health Minister J.P. Nadda, along with Bollywood actress and UNICEF Goodwill Ambassador Priyanka Chopra, launched the nationwide Weekly Iron and Folic Acid Supplement (WISF) awareness campaign here.
- Read more about Coconut board launches diabetic-friendly biscuits
The CDB Institute of Technology under the Coconut Development Board (CDB), which aims at innovations in the coconut industry, on Wednesday launched diabetic-friendly coconut biscuits.
- Read more about Cancer mitigation, prevention challenge for doctors: President
With increasing cases of cancer across the country, the medical fraternity and policy planners face the challenge of mitigating and preventing the dreaded disease, President Pranab Mukherjee said here on Wednesday.

[adsense:336x280:8701650588]
- Read more about Boehringer Ingelheim Expands Biopharmaceutical Production at Vienna Site
Boehringer Ingelheim will make a significant investment in biopharmaceutical production at its Vienna (Austria) site. There the research-driven pharmaceutical company will establish a new large-scale biopharmaceutical production facility for active ingredients manufactured using cell cultures. With the roughly half billion euro investment Boehringer Ingelheim will also create more than 400 new jobs in the Austrian capital. The exact investment and job numbers will be established as details are ironed out.
- Read more about FDA approves new orphan drug to treat pulmonary arterial hypertension
U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation. Uptravi is marketed by San Francisco-based Actelion Pharmaceuticals US, Inc.
- Read more about FDA approves Zurampic to treat high blood uric acid levels associated with gout
The U.S. Food and Drug Administration approved Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperuricemia) associated with gout, when used in combination with a xanthine oxidase inhibitor (XOI), a type of drug approved to reduce the production of uric acid in the body. Zurampic is manufactured by AstraZeneca Pharmaceuticals LP, based in Wilmington, Delaware.